This study assesses the accuracy of ChatGPT in conducting literature reviews by prompting the AI tool to find relevant articles based on established criteria from published systematic reviews. The findings reveal a concerning rate of inaccurate citations, highlighting the limitations of current generative AI in healthcare research and emphasizing the need for human oversight to ensure accuracy and reliability.

This study investigates the effectiveness of China’s Urgently Needed Overseas Drug (UNOD) policy, which aims to expedite access to innovative drugs for patients with unmet medical needs. Analyzing data from 2012 to 2019, the research reveals that the UNOD designation did not significantly reduce launch delays for new drugs compared to the United States. This finding suggests a potential overlap in benefits with other existing policies, undermining the intended prioritization of UNOD drugs.

This study highlights China's rapid development in pharmacoeconomics over two decades, driven by policy reforms, centralized drug procurement, and innovative pricing strategies. Despite progress, gaps remain in adopting global practices like real-world evidence and AI applications. China's drug price negotiations achieved a 60% average reduction, improving medication accessibility while balancing innovation and affordability.